Patient and Family Engagement
Cross-source consensus on Patient and Family Engagement from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Other
Highlighted claims
- Shared decision-making was viewed as essential because deprescribing should account for patient preferences and comfort as well as clinical evaluation. — Healthcare professionals’ barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study
- Patient education was considered important because patients who understand medication reduction are more likely to accept and follow the revised plan. — Healthcare professionals’ barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study
- Family influence can undermine deprescribing if relatives advise patients without consulting doctors or pressure them because of impatience with long-term therapy. — Healthcare professionals’ barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study
- Some patients and families interpret medication reduction positively as a sign of improved health and successful treatment. — Healthcare professionals’ barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study